- Home
- Publications
- Publication Search
- Publication Details
Title
Nasopharyngeal carcinoma: an evolving paradigm
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-30
DOI
10.1038/s41571-021-00524-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
- (2021) Feng-Hua Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
- (2021) Yu-Pei Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor for the Treatment of Tumors with Homozygous MTAP Deletion
- (2021) Zenon Konteatis et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy
- (2020) Daniela Alterio et al. ACTA ONCOLOGICA
- Wild-type IDH2 contributes to Epstein-Barr virus -dependent metabolic alterations and tumorigenesis
- (2020) Feng Shi et al. Molecular Metabolism
- Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal Carcinoma
- (2020) A.D. King et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis
- (2020) Bi-Cheng Wang et al. BMC CANCER
- Second cancer risk after primary cancer treatment with three‐dimensional conformal, intensity‐modulated, or proton beam radiation therapy
- (2020) Michael Xiang et al. CANCER
- Sequencing Analysis of Plasma Epstein-Barr Virus DNA Reveals Nasopharyngeal Carcinoma-Associated Single Nucleotide Variant Profiles
- (2020) W K Jacky Lam et al. CLINICAL CHEMISTRY
- Systemic chemotherapy and sequential locoregional radiotherapy in initially metastatic nasopharyngeal carcinoma: Retrospective analysis with 821 cases
- (2020) Tianying Huang et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015)
- (2020) Yasumasa Nishimura et al. International Journal of Clinical Oncology
- Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory study
- (2020) Ling Li et al. INVESTIGATIONAL NEW DRUGS
- Network-meta-analysis of chemotherapy in nasopharyngeal carcinoma (MAC-NPC): An update on 8,221 patients.
- (2020) Claire Petit et al. JOURNAL OF CLINICAL ONCOLOGY
- First-in-human dose-escalation study of anti-EGFR ADC MRG003 in patients with relapsed/refractory solid tumors.
- (2020) Rui-hua Xu et al. JOURNAL OF CLINICAL ONCOLOGY
- Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma (NPC).
- (2020) Robert John Walsh et al. JOURNAL OF CLINICAL ONCOLOGY
- The efficacy and toxicity of induction chemotherapy plus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma
- (2020) Peirong Wang et al. MEDICINE
- The efficacy and safety of PD-1/PD-L1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis
- (2020) Bi-Cheng Wang et al. ORAL ONCOLOGY
- Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
- (2020) Pok Man Hau et al. Frontiers in Oncology
- Integrating postradiotherapy plasma Epstein–Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy
- (2020) E.P. Hui et al. ANNALS OF ONCOLOGY
- NPC‐0501 trial on the value of changing chemoradiotherapy sequence, replacing 5‐fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma
- (2020) Anne W. M. Lee et al. CANCER
- Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
- (2020) Yu-Pei Chen et al. CELL RESEARCH
- Proton pencil-beam scanning radiotherapy in the treatment of nasopharyngeal cancer: dosimetric parameters and 2-year results
- (2020) Kubeš Jiří et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Pre-treatment intravoxel incoherent motion diffusion-weighted imaging predicts treatment outcome in nasopharyngeal carcinoma
- (2020) Sahrish Qamar et al. EUROPEAN JOURNAL OF RADIOLOGY
- Pre-treatment amide proton transfer imaging predicts treatment outcome in nasopharyngeal carcinoma
- (2020) Sahrish Qamar et al. EUROPEAN RADIOLOGY
- A gene-expression predictor for efficacy of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma
- (2020) Yuan Lei et al. JNCI-Journal of the National Cancer Institute
- Proton therapy for head and neck squamous cell carcinomas: A review of the physical and clinical challenges
- (2020) Arnaud Beddok et al. RADIOTHERAPY AND ONCOLOGY
- Emerging radiotherapy technologies and trends in nasopharyngeal cancer
- (2020) Michelle Tseng et al. Cancer Communications
- Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma
- (2020) Shanzhao Jin et al. CELL RESEARCH
- Circular RNAs in nasopharyngeal carcinoma
- (2020) Mingxiu Yang et al. CLINICA CHIMICA ACTA
- Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma
- (2020) Wan Qin Chong et al. CLINICAL CANCER RESEARCH
- Toxicity and dosimetric analysis of nasopharyngeal carcinoma patients undergoing radiotherapy with IMRT or VMAT: A regional center's experience
- (2020) Ling He et al. ORAL ONCOLOGY
- Saliva electrolyte analysis and xerostomia-related quality of life in nasopharyngeal carcinoma patients following intensity-modulated radiation therapy
- (2020) Xinmiao Lan et al. RADIOTHERAPY AND ONCOLOGY
- Joining Forces: Improving Clinical Response to Cellular Immunotherapies with Small-Molecule Inhibitors
- (2020) Debottam Sinha et al. TRENDS IN MOLECULAR MEDICINE
- Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2020) P. Bossi et al. ANNALS OF ONCOLOGY
- Cost-Effectiveness of Nasopharyngeal Carcinoma Screening With Epstein-Barr Virus Polymerase Chain Reaction or Serology in High-Incidence Populations Worldwide
- (2020) Jacob A Miller et al. JNCI-Journal of the National Cancer Institute
- Treatment Deescalation Strategies for Nasopharyngeal Cancer
- (2020) Anna Lee et al. JAMA Oncology
- Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy
- (2019) Xue-Song Sun et al. BMC CANCER
- Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial
- (2019) Wen-Fei Li et al. INTERNATIONAL JOURNAL OF CANCER
- Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control
- (2019) Sati Akbaba et al. Cancers
- Deep Learning for Automated Contouring of Primary Tumor Volumes by MRI for Nasopharyngeal Carcinoma
- (2019) Li Lin et al. RADIOLOGY
- Current Treatment Landscape of Nasopharyngeal Carcinoma and Potential Trials Evaluating the Value of Immunotherapy
- (2019) Quynh Thu Le et al. JNCI-Journal of the National Cancer Institute
- Plasma Epstein-Barr virus DNA as an archetypal circulating tumour DNA marker
- (2019) Wai Kei Jacky Lam et al. JOURNAL OF PATHOLOGY
- Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma
- (2019) Xiao-Yun Li et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and toxicity of proton with photon radiation for locally advanced nasopharyngeal carcinoma
- (2019) Arnaud Beddok et al. ACTA ONCOLOGICA
- Prognostic Value of the Pretreatment Primary Lesion Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Nasopharyngeal Carcinoma
- (2019) Yuhui Qin et al. ACADEMIC RADIOLOGY
- Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma
- (2019) A D King et al. ANNALS OF ONCOLOGY
- The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
- (2019) Zi-Lu Huang et al. Cancer Cell International
- Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10-Year Results of a Phase 2 Study
- (2019) Chong Zhao et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Preliminary results with tislelizumab, an investigational anti-PD-1 antibody, in Chinese patients with nasopharyngeal cancer (NPC).
- (2019) Siyang Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Recombinant humanized anti-PD-1 monoclonal antibody (JS001) in patients with refractory/metastatic nasopharyngeal carcinoma: Interim results of an open-label phase II clinical study.
- (2019) Fenghua Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma
- (2019) F. Dionisi et al. ACTA ONCOLOGICA
- Roles and Regulation of Long non-coding RNAs in Hepatocellular Carcinoma
- (2019) Lee Jin Lim et al. CANCER RESEARCH
- Early clinical outcomes of helical tomotherapy/intensity‐modulated proton therapy combination in nasopharynx cancer
- (2019) Seung Gyu Park et al. CANCER SCIENCE
- Molecular Prognostic Value of Circulating Epstein–Barr Viral DNA in Nasopharyngeal Carcinoma: A Meta-Analysis of 27,235 Cases in the Endemic Area of Southeast Asia
- (2019) Xulin Xie et al. Genetic Testing and Molecular Biomarkers
- International Guideline on Dose Prioritization and Acceptance Criteria in Radiotherapy Planning for Nasopharyngeal Carcinoma
- (2019) Anne W. Lee et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Nasopharyngeal carcinoma
- (2019) Yu-Pei Chen et al. LANCET
- Automatic segmentation for adaptive planning in nasopharyngeal carcinoma IMRT: Time, geometrical, and dosimetric analysis
- (2019) Nelson Tsz Cheong Fung et al. Medical Dosimetry
- Genome sequencing analysis identifies Epstein–Barr virus subtypes associated with high risk of nasopharyngeal carcinoma
- (2019) Miao Xu et al. NATURE GENETICS
- Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
- (2019) Yuan Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases
- (2019) W. K. Jacky Lam et al. Nature Communications
- Targeted sequencing of cancer-related genes in nasopharyngeal carcinoma identifies mutations in the TGF-β pathway
- (2019) An-Ko Chung et al. Cancer Medicine
- Management of locally recurrent nasopharyngeal carcinoma
- (2019) Anne W.M. Lee et al. CANCER TREATMENT REVIEWS
- Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial
- (2019) Qi Yang et al. EUROPEAN JOURNAL OF CANCER
- Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer – A prospective cohort analysis
- (2019) Kiattisa Sommat et al. RADIOTHERAPY AND ONCOLOGY
- Translational genomics of nasopharyngeal cancer
- (2019) Chi Man Tsang et al. SEMINARS IN CANCER BIOLOGY
- Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China
- (2019) M F Ji et al. ANNALS OF ONCOLOGY
- Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinoma
- (2019) Yabing Cao et al. BMC CANCER
- Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma
- (2019) Jiawei Lv et al. Nature Communications
- Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis
- (2019) Ya-Qin Wang et al. Journal for ImmunoTherapy of Cancer
- Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma
- (2019) Ricard Mesia et al. EUROPEAN JOURNAL OF CANCER
- Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
- (2018) R L Hong et al. ANNALS OF ONCOLOGY
- Risk, pattern and survival impact of second primary tumors in patients with nasopharyngeal carcinoma following definitive intensity-modulated radiotherapy
- (2018) James C.H. Chow et al. Asia-Pacific Journal of Clinical Oncology
- Prospective evaluation of plasma Epstein–Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma
- (2018) Brigette Ma et al. BRITISH JOURNAL OF CANCER
- Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results
- (2018) Jiyi Hu et al. CANCER
- Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study
- (2018) Edwin P. Hui et al. CLINICAL CANCER RESEARCH
- Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials
- (2018) Yu-Pei Chen et al. CLINICAL CANCER RESEARCH
- Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
- (2018) Brigette B.Y. Ma et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
- (2018) Anthony T.C. Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial
- (2018) Lin-Quan Tang et al. LANCET ONCOLOGY
- Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study
- (2018) Xin-Ran Tang et al. LANCET ONCOLOGY
- Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)
- (2018) K.H. Au et al. ORAL ONCOLOGY
- Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma
- (2018) W. K. Jacky Lam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: A systematic review and meta-analysis
- (2018) Teng Hwee Tan et al. RADIOTHERAPY AND ONCOLOGY
- International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
- (2018) Anne W. Lee et al. RADIOTHERAPY AND ONCOLOGY
- DNMT1 mediates metabolic reprogramming induced by Epstein–Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma
- (2018) Xiangjian Luo et al. Cell Death & Disease
- Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors
- (2018) Aaron M. Goodman et al. JAMA Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The addition of pretreatment plasma Epstein-Barr virus DNA into the 8th edition of nasopharyngeal cancer TNM stage classification
- (2018) Victor Ho-Fun Lee et al. INTERNATIONAL JOURNAL OF CANCER
- A phase I/II Trial of CRISPR-Cas9-mediated PD-1 knockout Epstein-Barr virus cytotoxic lymphocytes (EBV-CTLs) for advanced stage EBV associated malignancies.
- (2018) Jia Wei et al. JOURNAL OF CLINICAL ONCOLOGY
- Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
- (2018) Wenfeng Fang et al. LANCET ONCOLOGY
- Which nasopharyngeal cancer patients need adaptive radiotherapy?
- (2018) Yu-Chang Hu et al. BMC CANCER
- Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma
- (2018) Rui Guo et al. CANCER
- Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection
- (2018) You-Ping Liu et al. LARYNGOSCOPE
- Nasopharyngeal carcinoma radiotherapy with hybrid technique
- (2018) Ugur Akbas et al. Medical Dosimetry
- Trial watch: The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
- (2018) Jun Tang et al. NATURE REVIEWS DRUG DISCOVERY
- Intensity modulated proton therapy (IMPT) – The future of IMRT for head and neck cancer
- (2018) Amy C. Moreno et al. ORAL ONCOLOGY
- Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx
- (2018) Qi-Yong Ai et al. ORAL ONCOLOGY
- Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma
- (2018) Weitao Lin et al. Nature Communications
- Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-Term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013
- (2018) Lu-Lu Zhang et al. Cancer Research and Treatment
- Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
- (2017) Su-Mei Cao et al. EUROPEAN JOURNAL OF CANCER
- Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial
- (2017) Lei Chen et al. EUROPEAN JOURNAL OF CANCER
- Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatment
- (2017) Xiong Zou et al. EUROPEAN JOURNAL OF CANCER
- Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis
- (2017) Yiat Horng Leong et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: Focus on low-risk areas
- (2017) Greta Carioli et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score–Weighted Analysis
- (2017) Jean-Emmanuel Bibault et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
- (2017) Chiun Hsu et al. JOURNAL OF CLINICAL ONCOLOGY
- What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis
- (2017) Laureen Ribassin-Majed et al. JOURNAL OF CLINICAL ONCOLOGY
- Proton therapy for head and neck cancer: expanding the therapeutic window
- (2017) Jonathan E Leeman et al. LANCET ONCOLOGY
- Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma
- (2017) Qingfang Li et al. MEDICINE
- Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer
- (2017) K.C. Allen Chan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prediction of distant metastases from nasopharyngeal carcinoma: Improved diagnostic performance of MRI using nodal volume in N1 and N2 stage disease
- (2017) Qi-Yong Ai et al. ORAL ONCOLOGY
- Prognostic impact of adjuvant chemotherapy in high-risk nasopharyngeal carcinoma patients
- (2017) Yi-Chun Liu et al. ORAL ONCOLOGY
- Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations
- (2017) Yvonne Y Li et al. Nature Communications
- PD-L1 predicts poor prognosis for nasopharyngeal carcinoma irrespective of PD-1 and EBV-DNA load
- (2017) Yajuan Zhou et al. Scientific Reports
- Chemoradiotherapy Versus Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: A Systemic Review and Meta-analysis of 2138 Patients
- (2017) Cheng Xu et al. Journal of Cancer
- Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes
- (2017) Qian Zhu et al. OncoImmunology
- Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical response
- (2017) Corey Smith et al. OncoImmunology
- Use of Radiation Therapy in Metastatic Nasopharyngeal Cancer Improves Survival: A SEER Analysis
- (2017) Jiyi Hu et al. Scientific Reports
- The immunologic advantage of recurrent nasopharyngeal carcinoma from the viewpoint of Galectin-9/Tim-3-related changes in the tumour microenvironment
- (2017) Tseng-Cheng Chen et al. Scientific Reports
- Use of auto-segmentation in the delineation of target volumes and organs at risk in head and neck
- (2016) Jia Yi Lim et al. ACTA ONCOLOGICA
- A systematic review of the cost and cost-effectiveness studies of proton radiotherapy
- (2016) Vivek Verma et al. CANCER
- Oral Hygiene and Risk of Nasopharyngeal Carcinoma--A Population-Based Case-Control Study in China
- (2016) Z. Liu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Chromatin Remodeling Factor LSH Drives Cancer Progression by Suppressing the Activity of Fumarate Hydratase
- (2016) Xiaozhen He et al. CANCER RESEARCH
- Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival
- (2016) Yun-hong Tian et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses
- (2016) Jack Phan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes
- (2016) Paul B. Romesser et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
- (2016) Li Zhang et al. LANCET
- Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
- (2016) Ying Sun et al. LANCET ONCOLOGY
- Multimodality Treatment May Improve the Survival Rate of Patients with Metastatic Nasopharyngeal Carcinoma with Good Performance Status
- (2016) Wei Zheng et al. PLoS One
- Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma
- (2016) Victor H. F. Lee et al. PLoS One
- Whole-exome sequencing identifiesMST1Ras a genetic susceptibility gene in nasopharyngeal carcinoma
- (2016) Wei Dai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma
- (2016) Hong Zheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers
- (2016) Lili Li et al. Scientific Reports
- Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy
- (2015) Jian Ji Pan et al. CANCER
- Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes
- (2015) Gary D. Lewis et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Concurrent Chemo-Radiation With or Without Induction Gemcitabine, Carboplatin, and Paclitaxel: A Randomized, Phase 2/3 Trial in Locally Advanced Nasopharyngeal Carcinoma
- (2015) Terence Tan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)
- (2015) B. B. Y. Ma et al. INVESTIGATIONAL NEW DRUGS
- Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective
- (2015) Anne W.M. Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
- (2015) Pierre Blanchard et al. LANCET ONCOLOGY
- Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma
- (2015) Jianwei Zhang et al. MEDICAL ONCOLOGY
- Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma
- (2015) W. Jiang et al. MOLECULAR CANCER THERAPEUTICS
- Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis
- (2015) Binglan Zhang et al. ORAL ONCOLOGY
- Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1–T3 nasopharyngeal carcinoma – A case-matched comparison
- (2015) Rui You et al. RADIOTHERAPY AND ONCOLOGY
- Multi-subject atlas-based auto-segmentation reduces interobserver variation and improves dosimetric parameter consistency for organs at risk in nasopharyngeal carcinoma: A multi-institution clinical study
- (2015) Chang-Juan Tao et al. RADIOTHERAPY AND ONCOLOGY
- CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines
- (2015) Charlotte L. Brouwer et al. RADIOTHERAPY AND ONCOLOGY
- Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes
- (2015) Lili Li et al. Epigenomics
- Identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinoma
- (2015) Jeff P. Bruce et al. Oncotarget
- Sequential Cytokine-Induced Killer Cell Immunotherapy Enhances the Efficacy of the Gemcitabine Plus Cisplatin Chemotherapy Regimen for Metastatic Nasopharyngeal Carcinoma
- (2015) Yin Li et al. PLoS One
- EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
- (2015) Wenfeng Fang et al. Oncotarget
- Prognostic value of the primary lesion apparent diffusion coefficient (ADC) in nasopharyngeal carcinoma: a retrospective study of 541 cases
- (2015) Yuan Zhang et al. Scientific Reports
- Epstein-Barr Virus Serology as a Potential Screening Marker for Nasopharyngeal Carcinoma among High-Risk Individuals from Multiplex Families in Taiwan
- (2014) A. E. Coghill et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Metronomic Adjuvant Chemotherapy Improves Treatment Outcome in Nasopharyngeal Carcinoma Patients With Postradiation Persistently Detectable Plasma Epstein-Barr Virus Deoxyribonucleic Acid
- (2014) Chih-Wen Twu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The genomic landscape of nasopharyngeal carcinoma
- (2014) De-Chen Lin et al. NATURE GENETICS
- Etiological factors of nasopharyngeal carcinoma
- (2014) Sai Wah Tsao et al. ORAL ONCOLOGY
- Individualized treatment in stage IVC nasopharyngeal carcinoma
- (2014) Oscar S.H. Chan et al. ORAL ONCOLOGY
- Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma
- (2013) X. Wu et al. ANNALS OF ONCOLOGY
- Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program
- (2013) K. C. Allen Chan et al. CANCER
- Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma
- (2013) Lin Kong et al. CANCER
- Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of Ch
- (2013) Yong Chen et al. CANCER
- Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein-Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients
- (2013) E. P. Hui et al. CANCER RESEARCH
- FEZF2 , a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma
- (2013) Xing-sheng Shu et al. CARCINOGENESIS
- Cytotoxic T Cell Adoptive Immunotherapy as a Treatment for Nasopharyngeal Carcinoma
- (2013) Viviana P. Lutzky et al. Clinical and Vaccine Immunology
- Dosimetric difference amongst 3 techniques: TomoTherapy, sliding-window intensity-modulated radiotherapy (IMRT), and RapidArc radiotherapy in the treatment of late-stage nasopharyngeal carcinoma (NPC)
- (2013) Francis Kar-ho Lee et al. Medical Dosimetry
- Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma
- (2013) Whay-Kuang Chia et al. MOLECULAR THERAPY
- Value of Magnetic Resonance Diffusion-Weighted Imaging for the Prediction of Radiosensitivity in Nasopharyngeal Carcinoma
- (2013) Jinsheng Hong et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines
- (2013) Vincent Grégoire et al. RADIOTHERAPY AND ONCOLOGY
- Two Epstein-Barr Virus-Related Serologic Antibody Tests in Nasopharyngeal Carcinoma Screening: Results From the Initial Phase of a Cluster Randomized Controlled Trial in Southern China
- (2012) Z. Liu et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Effective Treatment of Metastatic Forms of Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive Immunotherapy
- (2012) C. Smith et al. CANCER RESEARCH
- Replanning During Intensity Modulated Radiation Therapy Improved Quality of Life in Patients With Nasopharyngeal Carcinoma
- (2012) Haihua Yang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis
- (2012) Na Liu et al. LANCET ONCOLOGY
- Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells
- (2012) C. M. Tsang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
- (2012) Herbert H. Loong et al. RADIOTHERAPY AND ONCOLOGY
- Familial and large-scale case–control studies identify genes associated with nasopharyngeal carcinoma
- (2012) Jin-Xin Bei et al. SEMINARS IN CANCER BIOLOGY
- Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches
- (2012) Kwok-Wai Lo et al. SEMINARS IN CANCER BIOLOGY
- Challenges in the modification of the M1 stage of the TNM staging system for nasopharyngeal carcinoma: A study of 1027 cases and review of the literature
- (2012) CHANG-CHUAN PAN et al. Experimental and Therapeutic Medicine
- A Phase II Trial of Erlotinib as Maintenance Treatment After Gemcitabine Plus Platinum-based Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma
- (2011) Benoit You et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation
- (2011) E. P. Hui et al. ANNALS OF ONCOLOGY
- Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation
- (2011) G. Fountzilas et al. ANNALS OF ONCOLOGY
- Volumetric modulated arc therapy: a review of current literature and clinical use in practice
- (2011) M Teoh et al. BRITISH JOURNAL OF RADIOLOGY
- A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma
- (2011) Wan-Teck Lim et al. CLINICAL CANCER RESEARCH
- A Retrospective Comparison of Robotic Stereotactic Body Radiotherapy and Three-Dimensional Conformal Radiotherapy for the Reirradiation of Locally Recurrent Nasopharyngeal Carcinoma
- (2011) Gokhan Ozyigit et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial
- (2011) Qiu-Yan Chen et al. JNCI-Journal of the National Cancer Institute
- EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin
- (2011) Z-T Tong et al. ONCOGENE
- The Epigenetic Modifier PRDM5 Functions as a Tumor Suppressor through Modulating WNT/β-Catenin Signaling and Is Frequently Silenced in Multiple Tumors
- (2011) Xing-sheng Shu et al. PLoS One
- Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101 and miR-98
- (2011) N M Alajez et al. Cell Death & Disease
- Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5- fluorouracil in locally advanced nasopharyngeal carcinoma
- (2011) Tanadech Dechaphunkul et al. Head and Neck Optical Diagnostics Society
- Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma
- (2010) Chrystal U. Louis et al. JOURNAL OF IMMUNOTHERAPY
- Expression of Epstein-Barr virus-encoded LMP1 and hTERT extends the life span and immortalizes primary cultures of nasopharyngeal epithelial cells
- (2010) Yim-Ling Yip et al. JOURNAL OF MEDICAL VIROLOGY
- Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma
- (2010) A. W. M. Lee et al. JNCI-Journal of the National Cancer Institute
- Primary Nasopharyngeal Carcinoma: Diagnostic Accuracy of MR Imaging versus that of Endoscopy and Endoscopic Biopsy
- (2010) Ann D. King et al. RADIOLOGY
- A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma
- (2010) Anne W.M. Lee et al. RADIOTHERAPY AND ONCOLOGY
- Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer
- (2009) Woo Kyun Bae et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Outcomes of nasopharyngeal carcinoma screening for high risk family members in Hong Kong
- (2009) Wai Tong Ng et al. Familial Cancer
- The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells
- (2009) Li-Bing Song et al. JOURNAL OF CLINICAL INVESTIGATION
- Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells
- (2008) Huaying Liu et al. BMC CANCER
- Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma
- (2008) Daniel T. T. Chua et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma
- (2008) Edwin P. Hui et al. JOURNAL OF CLINICAL ONCOLOGY
- Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma
- (2008) Anne W.M. Lee et al. RADIOTHERAPY AND ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search